utmd8k20100507.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): May 7, 2010


Commission File No. 001-12575


         UTAH MEDICAL PRODUCTS, INC.         
(Exact name of Registrant as specified in its charter)


                    UTAH                   
      87-0342734      
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)


7043 South 300 West
               Midvale, Utah  84047              
Address of principal executive offices


Registrant's telephone number:         (801) 566-1200

 
 
 

ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
 
On May 7, 2010 at the annual meeting, shareholders of the Company approved the following matters submitted to them for consideration:

Elected Barbara A. Payne as a director of the Company:
 
For
2,743,217
Withheld
81,491
Broker Non-Votes
412,898

Ratified the selection of Jones, Simkins P.C. as the Company’s independent public accounting firm for the year ended December 31, 2010:
 
For
3,203,485
Against
12,725
Abstentions
12,396


SIGNATURES
 
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
   
   
Date:         5/11/2010         
By:      /s/ Kevin L. Cornwell    
 
       Kevin L. Cornwell
 
       CEO